Navigation Links
Eligard(R) six-month formulation successfully completes European approval procedure
Date:8/31/2007

ls of testosterone in the body, which may result in a reduction of symptoms related to the disease. Sustained levels of leuprolide decrease testosterone levels to suppress tumor growth in patients with hormone-responsive prostate cancer. The liquid Eligard products are injected subcutaneously with a small gauge needle, forming a solid implant in the body that slowly releases leuprolide as the implant is bioabsorbed.

About QLT

QLT Inc. is a global biopharmaceutical company dedicated to the discovery, development and commercialization of innovative therapies. Our research and development efforts are focused on pharmaceutical products in the fields of ophthalmology and dermatology. In addition, we utilize two unique technology platforms, photodynamic therapy and Atrigel(R), to create products such as Visudyne(R) and Eligard(R). For more information, visit our web site at http://www.qltinc.com.

Atrigel is a registered trademark of QLT USA, Inc.

Visudyne is a registered trademark of Novartis AG.

Eligard is a registered trademark of Sanofi-aventis.

QLT Inc. is listed on The NASDAQ Stock Market under the trading symbol "QLTI" and on The Toronto Stock Exchange under the trading symbol "QLT."

Certain statements in this press release constitute "forward-looking statements" of QLT within the meaning of the Private Securities Litigation Reform Act of 1995 and constitute "forward-looking information" within the meaning of the Securities Act (Ontario). Such statements include, but are not limited to, the statement with respect to our belief that the successful completion of the European approval procedure will contribute to future product growth, our expectations as to the launch of the six-month formulation in 23 other European countries, the statement projecting Eligard annual sales, and statements containing words such as "expects," "believes," "potential" and similar expressions that d
'/>"/>

SOURCE QLT Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Novel "CYCLOSPORINE CAPSULE FORMULATION" to be launched
2. Ajanta Launches Worlds First Once-A-Day Nimesulide Oral Formulation
3. Drug regulatory officials giving the nod for sale of Unapproved drug formulations in India
4. Indian Government Keen On JE Vaccine Supply And Patenting Of Indian Medicine Formulations
5. Endangered species may be successfully cloned in another animals womb
6. AIDS bias successfully overcome by Indian Muslims in South Africa
7. French Doctors Successfully Separate Twins Joined At Spine
8. Australian Surgeons Successfully Conduct Worlds First Triple Organ Transplant
9. Alzheimer’s disease trial With EVT 101 For Successfully Complete
10. First Ever Face Transplant In China Successfully Performed
11. Third Arm Removed Successfully
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2014)... Hospital Pediatrician-in-Chief Jon McCullers, MD, was recently invited ... of Nature Reviews Microbiology , one of ... a world-renowned infectious disease specialist, and chair of ... Tennessee Health Science Center, analyzed the epidemiology and ... 1968 pandemics, as well as more recent 2009 ...
(Date:4/17/2014)... 10 million older Americans suffer from depression, often brought ... new research a project that followed the lives ... found that Internet use among the elderly can ... percent. , "That,s a very strong effect," said Shelia ... studies and media who led the project. "And it ...
(Date:4/17/2014)... BostonResearchers from Boston University School of Medicine (BUSM) ... alcohol consumption in an experimental model. The findings, ... and Alcohol Abuse , may lead to more ... alcohol is one of the leading causes of ... significant negative economic impact by limiting the productivity ...
(Date:4/17/2014)... Cesar A. Arias, M.D., Ph.D., at The University of ... a new superbug that caused a bloodstream infection in ... 17 issue of The New England Journal of ... a class of highly-resistant bacteria known as methicillin-resistant ... cause of hospital and community-associated infections. The superbug has ...
(Date:4/17/2014)... blood flow and alleviates muscle soreness after exercise, ... University of Illinois at Chicago. , The study, ... Archives of Physical Medicine and Rehabilitation , ... people who had not exercised, suggesting that massage ... of physical activity. , Improved circulation and relief ...
Breaking Medicine News(10 mins):Health News:Internet use can help ward off depression among elderly 2Health News:BUSM researchers find anti-seizure drug may reduce alcohol consumption 2Health News:New MRSA superbug emerges in Brazil 2Health News:Massage therapy improves circulation, eases muscle soreness 2
... ... ‘death panel’ claim as the year’s biggest lie. Finalist for biggest lies also include ... ... PolitiFact.com , the Pulitzer Prize-winning fact-checking Web site of the St. Petersburg Times, ...
... WASHINGTON, Dec. 20 Following is the daily "Profile America" feature ... , SUNDAY, DECEMBER 20: FIRST ORGAN TRANSPLANT , ... transplant in the U.S. was performed this week in 1954 in ... from one identical twin to another, who lived just over eight ...
... health care focuses on costs, a new study from North ... to think of health care spending as an investment that ... projections of health care costs and financing may be unduly ... investment in future capital, contributing to a productive workforce, rather ...
... , WASHINGTON, Dec. 19 Official statement ... , "Majority Leader Reid,s amendment to the Senate health care bill ... current federal law and policy. It does not prevent federal ... protect health care providers who choose to exercise their rights of ...
... , Calls on Senator Ben Nelson to Not ... Senate Majority Leader Harry Reid (D-Nev.) released his long awaited ... The new language is being trumpeted as including an opt-out ... bill worse by requiring the state to either cover all ...
... out of reach of little hands , SATURDAY, Dec. 19 ... at least judging by statistics from a single hospital, but ... say they should be on the list of seasonal safety ... children are treated at Children,s Hospital Boston,s emergency department each ...
Cached Medicine News:Health News:PolitiFact Names 'Death Panels' Claim the Lie of the Year 2Health News:U.S. Census Bureau Daily Feature for Dec. 20 2Health News:Study shows health care spending spurs economic growth 2Health News:Americans United for Life Action: 'Senate Health Care Bill Absolutely Fails To Meet Abortion and Life Protections.' 2Health News:Americans United for Life Action: 'Senate Health Care Bill Absolutely Fails To Meet Abortion and Life Protections.' 3Health News:FRC Rejects Phony Abortion 'Compromise' 2
(Date:1/15/2014)... Calif. , Jan. 15, 2014 Massachusetts ... (NASDAQ: AMGN ) announced today that ... discover and validate new therapeutic targets and develop ... chronic disorder that affects millions worldwide. The MGH-Broad-Amgen ...
(Date:1/15/2014)... LOUISVILLE, Ky. , Jan. 15, 2014  Manufacturers, ... technologies must be able to protect their most ... (Logo: http://photos.prnewswire.com/prnh/20130716/CL46586LOGO ) Because ... Industry, it steadfastly remains one of the most ...
(Date:1/15/2014)...  Echo Therapeutics, Inc. (Nasdaq: ECTE ) ("Echo"), ... as a non-invasive, wireless continuous glucose monitoring system, today ... and Interim CEO of Echo Therapeutics, will present at ... Mr. Doman will make a corporate ...
Breaking Medicine Technology:Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4Intellectual Property Insurance for Medical-related Products and Services 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3
... Conatus Pharmaceuticals Inc., a privately held, clinical stage ... Hepatitis C Virus (HCV), announced today that Steven J. ... at the Montgomery Healthcare Conference being held in Menlo ... of only 30 companies selected to present to this ...
... Hospital of Arcadia, California, has launched an integrated ... solutions designed to help improve the quality of ... health care information technology subsidiary of Quest Diagnostics ... solution to help Methodist reduce the length of ...
Cached Medicine Technology:Conatus Pharmaceuticals to Present at the Montgomery Healthcare Conference 2Methodist Hospital Adopts New Technology Solutions to Improve Care for California Patients and Reduce Operating Costs 2Methodist Hospital Adopts New Technology Solutions to Improve Care for California Patients and Reduce Operating Costs 3Methodist Hospital Adopts New Technology Solutions to Improve Care for California Patients and Reduce Operating Costs 4
The Optima III 45 cm line of laparoscopic hand instruments is ideal for operative laparoscopic/endoscopic procedures or when a longer instrument is needed....
The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability....
The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability....
The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability....
Medicine Products: